Clinical Trial

Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.

Study acronym: ARTSCAN V
Recruiting
View on ClinicalTrials.gov →
Summary
In this trial, patients with early squamous cell carcinoma of the tonsil with clinical stage T1-2 (p16-positive or p16-negative) N0-1 (p16-positive)/N0-N2b (p16-negative) according to American Joint Committee on Cancer (AJCC) 8th edition, aimed for unimodal and ipsilateral treatment with radiotherapy with curative intent will be included. The patients will be randomized to in a 1:1 ratio to receive radiotherapy with either photons (conventional radiotherapy) versus radiotherapy with protons.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-02-01; most recent amendment 2021-08-31.
Trial Details
NCT Number NCT03829033
Lead Sponsor Lund University Hospital
Conditions Tonsil Cancer
Enrollment 100 participants
Start Date 2019-01-22
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2021-09-01